These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
48. Development and validation of a high-performance liquid chromatography method for the evaluation of niflumic acid cross-reactivity of two commercial immunoassays for cannabinoids in urine. Kovatsi L, Pouliopoulos A, Papadaki A, Samanidou V, Tsoukali H. J Anal Toxicol; 2010 May; 34(4):229-32. PubMed ID: 20465870 [Abstract] [Full Text] [Related]
49. Fluorescence polarization immunoassay evaluated for screening for amphetamine and methamphetamine in urine. Caplan YH, Levine B, Goldberger B. Clin Chem; 1987 Jul; 33(7):1200-2. PubMed ID: 3297420 [Abstract] [Full Text] [Related]
51. Mechanism of false-negative urine cannabinoid immunoassay screens by Visine eyedrops. Pearson SD, Ash KO, Urry FM. Clin Chem; 1989 Apr; 35(4):636-8. PubMed ID: 2467764 [Abstract] [Full Text] [Related]
52. Urinary screening for midazolam and its major metabolites with the Abbott ADx and TDx analyzers and the EMIT d.a.u. benzodiazepine assay with confirmation by GC/MS. Fraser AD, Bryan W, Isner AF. J Anal Toxicol; 1991 Apr; 15(1):8-12. PubMed ID: 2046344 [Abstract] [Full Text] [Related]